Here is what you need to know on Monday, November 23:
The greenback retained its weak tone against most major rivals, but major pairs held within familiar levels. Market players look beyond macroeconomic data, maintaining the focus in coronavirus-related news.
Several front-runner companies developing vaccines to prevent COVID-19 have reported early results from their stage three test, providing encouraging results. Yet, at the same time, the world reported 11,752 new coronavirus deaths on Friday, making it the deadliest day since the pandemic began. Such numbers result in different restrictive measures that could be translated into a slower economic recovery yet to be seen and a steeper downturn before the comeback.
Regarding Brexit talks, European Commission president Ursula von der Leyen said on Friday that “better progress” was made, although she added that “there are still quite some metres to the finish line.” Market talks suggest that an announcement could be made this week. Hopes that the UK and the EU may clinch a trade deal underpin sterling.
US indexes closed in the red on Friday, while US Treasury yields settled near weekly lows, reflecting the dismal mood.
Gold managed to post a modest intraday advance on Friday, ending the week in the red at $1,870.00 a troy ounce. Tensions between US Federal Reserve chief Jerome Powell and US Treasury Secretary Steve Mnuchin over pandemic-relief funds.
This Monday, Markit will publish the preliminary estimates of November PMIs for several major economies, a hint on economic health.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.